Click on image to view ad details and full-size version on AdPharm.

What could you do with 15 letters?
Show her the world.

Give your patients a chance to gain as many lines as possible.

Lucentis is the first and only therapy proven to deliver a 3-line gain in up to 41% of patients at 2 years with monthly dosing (vs 4% with sham and 6% withverteporfin PDT)

Nearly all Lucentis-treated patients – 90% – maintained vision at 2 years (vs 53% with sham and 66% with verteporfin PDT)

Brand name: Lucentis
Generic name/category: Ranibizumab, Ophtalmology
Company: Genentech
Country/Market: USA, North America
Indication(s)/use: neovascular (wet) age-related macular degeneration
Target: Healthcare Professionals (HCP)
Tagline: Lines gained. Lives changed.
Publication: Ophtalmology Times June 2009

To see all of this brand’s ads on AdPharm, click here

Drops over the next 18 years: 13140

As a doctor, you know hell need IOP-lowering for the long term.

Keep this in mind and prescribe BAK-free Travatan Z Solution.

Brand name: Travatan Z
Generic name/category: Travoprost, Ophtalmology
Company: Alcon
Country/Market: USA, North America
Indication(s)/use: Reduction of elevated Intraocular Pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Target: Healthcare Professionals (HCP)
Publication: Ophtalmology Times June 2009